Effects of smoking on plasma antimüllerian hormone concentrations among infertile women;El hábito de fumar se asocia a baja concentración plasmática de hormona antimülleriana en mujeres infértiles

Revista Medica de Chile

Volumn 141, Issue 1, 2013, Pages 23-27

  Fuentes, Ariel ^a   Escalona, Javier ^a   Céspedes, Pablo ^a   Repetto, Victoria ^a   Iñiguez, German ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Age factors; Anti mullerian hormone; Infertility; Smoking

Indexed keywords

BIOLOGICAL MARKER; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BLOOD; FEMALE; FEMALE INFERTILITY; HUMAN; METABOLISM; NONPARAMETRIC TEST; OVARY; SMOKING; STATISTICAL MODEL;

ADULT; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFERTILITY, FEMALE; LINEAR MODELS; OVARY; SMOKING; STATISTICS, NONPARAMETRIC;

EID: 84878146673     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872013000100003     Document Type: Article

References (17)

1. Midgette AS, Baron JA. Cigarette smoking and the risk of natural menopause. Epidemiology 1990; 1 (6): 474-80.
2. Adena MA, Gallagher HG. Cigarette smoking and the age at menopause. Ann Hum Biol 1982; 9 (2): 121-130.
3. Cooper GS, Baird DD, Hulka BS, Weinberg CR, Savitz DA, Hughes CL. Follicle-stimulating hormone concentrations in relation to active and passive smoking. Obstet Gynecol 1995; 85 (3): 407-11.
4. Seifer DB, Maclaughlin DT. Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertil Steril 2007; 88 (3): 539-46.
5. Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N. A prospective, comparative analysis of anti-mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril 2010; 93 (3): 855-64.
6. Kevenaar ME, Meerasahib MF, Kramer P. Serum antimü-llerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 2006; 147 (7): 3228-34.
7. Hehenkamp WJ, Looman CW, Themmen AP, De Jong FH, Te Velde ER, Broekmans FJ. Anti-mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006; 91 (10): 4057-63.
8. Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy C, Englert Y. Stable serum levels of anti-mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod 2007; 22 (7): 1837-40.
9. Fuentes A, Muñoz A, Barnhart K, Argüello B, Díaz M, Pommer R. Recent cigarette smoking and assisted reproductive technologies outcome. Fertil Steril 2010; 93 (1): 89-95.
10. Fuentes A, Muñoz A, Pommer R, Argüello B, Galleguillos A, Torres A, et al. Decreased anti-Müllerian hormone concentration in follicular fluid of female smokers undergoing artificial reproductive techniques. Chemosphere 2012; 88 (4): 403-6.
11. La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, et al. Anti-mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod 2007; 22 (3): 766-71.
12. Freour T, Masson D, Dessolle L, Allaoua D, Dejoie T, Mirallie S, et al. Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation régimen. Arch Gynecol Obstet 2012; 285 (4): 1177-82.
13. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Carducci A, et al. Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Human Reproduction Update 2010; 16 (2): 113-30.
14. Plante B, Cooper G, Baird D, Steiner A.The impact of smoking on antimullerian hormone levels in women aged 38 to 50 years. Menopause 2010; 17 (3): 571-6.
15. Freour T, Masson D, Mirallie S, Jean M, Baoh K, Dejoie T, et al. Active smoking compromises IVF outcome and affects ovarian reserve. Reprod Biomed Online 2008; 16 (1): 96-102.
16. Sowers MR, McConnell D, Yosef M, Jannausch ML, Harlow SD, Randolph JF Jr. Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period. Ann N Y Acad Sci 2010; 1204 (1): 95-103.
17. Seifer DB, Golub ET, Lambert-Messerlian G, Benning L, Anastos K, Watts DH, et al. Variations in serum Müllerian inhibiting substance between white, black, and Hispanic women. Fertil Steril 2009; 92 (5): 1674-8.